Blueberry Extract and Resistance Training in Severe Pulmonary Arterial Hypertension: Effects on Lung and Right-Ventricle Function and Structure
This study evaluated the effects of blueberry extract and resistance training on lung and right ventricle (RV) function and structure in severe experimental pulmonary arterial hypertension (PAH). PAH was induced in male Wistar rats by a single intraperitoneal injection of monocrotaline (60 mg/kg). One day later, the animals started receiving blueberry extract (100 mg/kg daily by gavage) and underwent a three-week moderate-intensity resistance exercise protocol (ladder climbing—15 climbs, a 60 s interval, a 60% load, one session/day, 5 days/wk). After these treatments and echocardiographic assessment, the animals were euthanized, and lung and RV samples were collected for mechanical, morphological, biochemical, and molecular analyses. Both blueberry extract and resistance training attenuated RV dysfunction and pulmonary artery resistance observed over the development of severe PAH. In addition, single RV myocyte mechanical function was maintained in treated rats. Moreover, the applied treatments mitigated oxidative imbalance and adverse structural remodeling in both the lung and RV. Furthermore, the interventions promoted partial or complete preservation of calcium regulatory protein expression. In conclusion, blueberry extract and resistance training, either alone or in combination, alleviate cardiopulmonary oxidative imbalance and adverse structural remodeling, sustain RV myocyte contractility and the expression of calcium regulatory proteins, and thus conserve pulmonary and RV function in severe PAH induced by monocrotaline.
Authors
- Alex Sander da Rosa Araújo (ORCID: https://orcid.org/0000-0002-9482-7388)
- Patrick Türck (ORCID: https://orcid.org/0000-0001-5994-5218)
- Emily Correna Carlo Reis (ORCID: https://orcid.org/0000-0002-9794-6972)
- Antônio José Natali (ORCID: https://orcid.org/0000-0002-4927-4024)
- Matheus Soares Faria
- Bruno Rocha de Avila Pelozin (ORCID: https://orcid.org/0000-0002-9066-0488)
- Tiago Menezes Fernandes (ORCID: https://orcid.org/0000-0002-9057-3878)
- Luciano Bernardes Leite (ORCID: https://orcid.org/0000-0002-3012-1327)
- Leôncio Lopes Soares (ORCID: https://orcid.org/0000-0001-6852-1230)
- Luiz Otávio Guimarães‐Ervilha (ORCID: https://orcid.org/0000-0001-6355-2492)
- Pedro Miguel Forte (ORCID: https://orcid.org/0000-0003-0184-6780)
- Mariana Machado‐Neves (ORCID: https://orcid.org/0000-0002-7416-3529)
- Flávio Gilberto Herter (ORCID: https://orcid.org/0000-0001-9652-1756)
- Edilamar Menezes de Oliveira (ORCID: https://orcid.org/0000-0002-7101-312X)
- Sebastião Felipe Ferreira Costa (ORCID: https://orcid.org/0000-0003-1406-9511)
- Sara Caco dos Lúcio Generoso
- Arthur Eduardo de Carvalho Quintão (ORCID: https://orcid.org/0009-0005-3066-024X)
- Mirielly Alexia Miranda Xavier
- Thainá Iasbik-Lima
Institutions
- Universidade Federal de Juiz de Fora (BR)
- Universidade Federal do Rio Grande do Sul (BR)
- Universidade Federal de Viçosa (BR)
- Universidade Federal de Pelotas (BR)
- Polytechnic Institute of Bragança (PT)
Publication Details
- Journal
- Antioxidants
- Published
- 2026-09-24
- DOI
- https://doi.org/10.3390/antiox15101232
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00